Benchling Stock

benchling.comSaaSFounded: 2012Funding to Date: $424.97MM

Benchling is a biotechnology company and developer of a platform that allows researchers to design and run experiments, analyze data, and share results.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Benchling, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Sajith Wickramasekara
Co-Founder, Chief Executive Officer and Board Member
Kaiser Mulla-Feroze
Chief Marketing Officer
Ashutosh Singhal
Co-Founder and Board Member
Sherwin Yu
Engineering Manager

Board Members

Ashutosh Singhal
Balaji Srinivasan Ph.D
Andreessen Horowitz
Eric Vishria
Miles Grimshaw
Thrive Capital
Sajith Wickramasekara

Other companies like Benchling in the SaaS sector

Sector
Last Round Est. Valuation
$5.8B
Sector
Last Round Est. Valuation
$2.17B
Sector
Last Round Est. Valuation
$741.99MM
Sector
Last Round Est. Valuation
$3.52B
Sector
Last Round Est. Valuation
$2.58B
Sector
Last Round Est. Valuation
$12.45MM
Sector
Last Round Est. Valuation
$726.06MM
Sector
Last Round Est. Valuation
$1.63B
Sector
Last Round Est. Valuation
$1.13B

News

Benchling, which is backed by investors Andreessen Horowitz and Thrive Capital, is helping customers scale coronavirus research and testing.
Benchling's cloud-based R&D platform helps scientists make breakthrough discoveries faster.
Benchling, a San Francisco, CA-based life sciences R&D cloud platform, closed $50m in Series D funding